Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
10
MODV Quote, Financials, Valuation and Earnings
Last price:
$11.17
Seasonality move
:
12.09%
Day range:
$10.63 - $11.66
52-week range:
$10.63 - $52.33
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.06x
P/B ratio:
38.46x
Volume:
521.7K
Avg. volume:
205.1K
1-year change:
-72.11%
Market cap:
$159M
Revenue:
$2.8B
EPS (TTM):
-$12.88
Analysts' Opinion
-
Consensus RatingModivCare has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, ModivCare has an estimated upside of 130.61% from its current price of $11.13.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $11.13.
Fair Value
-
According to the consensus of 0 analysts, ModivCare has 130.61% upside to fair value with a price target of -- per share.
MODV vs. S&P 500
-
Over the past 5 trading days, ModivCare has underperformed the S&P 500 by -36.28% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
ModivCare does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
ModivCare has grown year-over-year revenues for 1 quarter straight. In the most recent quarter ModivCare reported revenues of $702M.
Earnings Growth
-
ModivCare earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter ModivCare reported earnings per share of -$1.87.
Enterprise value:
1.3B
EV / Invested capital:
1.11x
Price / LTM sales:
0.06x
EV / EBIT:
--
EV / Revenue:
0.48x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-13.92x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
82.04x
Gross Profit (TTM):
$432.5M
Return On Assets:
-10.61%
Net Income Margin (TTM):
-6.57%
Return On Equity:
-206.4%
Return On Invested Capital:
-15%
Operating Margin:
0.75%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $2.4B | $2.7B | $2.8B | $686.9M | $702M | |
| Gross Profit | $483M | $449.6M | $432.5M | $107.7M | $104.1M | |
| Operating Income | $70.6M | $34.1M | $23.9M | $12M | $5.3M | |
| EBITDA | $165.4M | -$45.3M | $16.2M | $38.1M | $21.4M | |
| Diluted EPS | -$4.02 | -$14.54 | -$12.88 | -$0.30 | -$1.87 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $379.3M | $470.7M | $381.7M | $387.9M | $463.4M | |
| Total Assets | $791.6M | $2.1B | $2B | $1.8B | $1.7B | |
| Current Liabilities | $270.6M | $576M | $533.5M | $516.9M | $581.5M | |
| Total Liabilities | $381.6M | $1.7B | $1.6B | $1.6B | $1.7B | |
| Total Equity | $410.1M | $404M | $354.1M | $158.9M | -$17M | |
| Total Debt | -- | $974.7M | $978.3M | $1.1B | $1.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $57.7M | -$113.3M | -$62.1M | $53.5M | $9.3M | |
| Cash From Investing | -$108.9M | -$38.6M | -$33.4M | -$8.9M | -$7.7M | |
| Cash From Financing | -$2.7M | $87.7M | $135.8M | -$43.5M | $36.3M | |
| Free Cash Flow | $24.7M | -$151.9M | -$95.5M | $44.7M | $1.5M | |
MODV
Sector
Market Cap
$159M
$44.6M
Price % of 52-Week High
21.27%
45.71%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.68%
1-Year Price Total Return
-72.11%
-29.09%
Beta (5-Year)
0.535
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$14.70
200-day SMA
Sell
Level
$22.21
Bollinger Bands (100)
Sell
Level
13.34 - 24.28
Chaikin Money Flow
Buy
Level
17.5M
20-day SMA
Sell
Level
$16.75
Relative Strength Index (RSI14)
Sell
Level
25.85
ADX Line
Sell
Level
13.78
Williams %R
Buy
Level
-94.0758
50-day SMA
Sell
Level
$16.31
MACD (12, 26)
Sell
Level
-1.17
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Neutral
Level
7.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.4303)
Sell
CA Score
(Annual)
Level (-1.8862)
Buy
Beneish M-Score
(Annual)
Level (-2.7612)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (3.0543)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.
Stock Forecast FAQ
In the current month, MODV has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MODV average analyst price target in the past 3 months is --.
-
Where Will ModivCare Stock Be In 1 Year?
According to analysts, the consensus estimate is that ModivCare share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About ModivCare?
Analysts are divided on their view about ModivCare share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that ModivCare is a Sell and believe this share price will drop from its current level to --.
-
What Is ModivCare's Price Target?
The price target for ModivCare over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MODV A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for ModivCare is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MODV?
You can purchase shares of ModivCare via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ModivCare shares.
-
What Is The ModivCare Share Price Today?
ModivCare was last trading at $11.17 per share. This represents the most recent stock quote for ModivCare. Yesterday, ModivCare closed at $11.13 per share.
-
How To Buy ModivCare Stock Online?
In order to purchase ModivCare stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
